Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,460 public trials 1,142 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

NCT01203839

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Follow-up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Follow-up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Follow-up Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk (Follow-up Only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

NCT02393794

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • University of Kansas Cancer Center - Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center - West Kansas City, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

NCT03734029

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Ironwood Cancer & Research Centers - Chandler II Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Treatment Centers of America at Western Regional Medical Center Goodyear, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
View all 208 locations
View Trial Details
Active, Not Recruiting

Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer

NCT02826434

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts general Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

NCT05654532

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Site 08 Denver, Colorado, United States
  • Site 07 Orlando, Florida, United States
  • Site 02 Sarasota, Florida, United States
  • Site 06 Rockville, Maryland, United States
View Trial Details
Active, Not Recruiting

Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

NCT03414684

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • The Stamford Hospital Stamford, Connecticut, United States
  • Eastern Maine Medical Center Bangor, Maine, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions